BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25714364)

  • 1. Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area.
    Castel AD; Young H; Akiwumi AM; Vargas A; Rogers K; West T; Levine PH
    AIDS Care; 2015; 27(7):860-9. PubMed ID: 25714364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
    Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
    HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
    Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
    Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].
    Jabłonowska E; Małolepsza E; Strycharz M; Wójcik K
    Przegl Epidemiol; 2011; 65(2):339-43. PubMed ID: 21913486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer in HIV-infected persons from the Caribbean, Central and South America.
    Fink VI; Shepherd BE; Cesar C; Krolewiecki A; Wehbe F; Cortés CP; Crabtree-Ramírez B; Padgett D; Shafaee M; Schechter M; Gotuzzo E; Bacon M; McGowan C; Cahn P; Masys D;
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):467-73. PubMed ID: 21239992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
    Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
    J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and the risk of cancers with and without a known infectious cause.
    Silverberg MJ; Chao C; Leyden WA; Xu L; Tang B; Horberg MA; Klein D; Quesenberry CP; Towner WJ; Abrams DI
    AIDS; 2009 Nov; 23(17):2337-45. PubMed ID: 19741479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancies in HIV: pre- and post-highly active antiretroviral therapy.
    Nutankalva L; Wutoh AK; McNeil J; Frederick WR; Reddy RB; Daftary M; Gentles A; Addae-Afoakwa K
    J Natl Med Assoc; 2008 Jul; 100(7):817-20. PubMed ID: 18672558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
    Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
    Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer burden in the HIV-infected population in the United States.
    Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
    J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
    Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
    Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
    Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
    Int J Cancer; 2015 Nov; 137(10):2443-53. PubMed ID: 25976897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
    Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
    HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years later: a single hospital experience with malignancy in HIV/AIDS.
    Reed M; Cosgrove JM; Cindrich R; Parithivel VS; Gad Y; Bangalore M; Uzor R; Kalim J; Segura R; Albu E
    J Surg Oncol; 2010 Sep; 102(3):282-6. PubMed ID: 20740588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors.
    Petoumenos K; Hui E; Kumarasamy N; Kerr SJ; Choi JY; Chen YM; Merati T; Zhang F; Lim PL; Sungkanuparph S; Pujari S; Ponnampalavanar S; Ditangco R; Lee CK; Grulich A; Law MG;
    J Int AIDS Soc; 2010 Dec; 13():51. PubMed ID: 21143940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
    Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
    Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
    Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
    AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.